Bioxytran Inc (BIXT)
US Market

Bioxytran (BIXT) Income Statement


Bioxytran Income Statement

Last quarter (Q ), Bioxytran's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Bioxytran's net income was $-1.41M. See Bioxytran’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
---$ 0.00$ 0.00$ 0.00
Cost of Revenue
Gross Profit
Operating Expense
$ -533.88K$ 2.13M$ 4.29M$ 1.27M$ 1.63M$ 215.11K
Operating Income
$ -1.27M$ -2.45M$ -4.29M$ -1.27M$ -1.63M$ -215.11K
Net Non Operating Interest Income Expense
$ 50.09K-$ 2.02M$ -1.27M$ -227.01K$ -81.31K
Other Income Expense
$ 207.31K----$ -72.41K
Pretax Income
$ -3.29M$ -2.66M$ -4.53M$ -2.54M$ -1.86M$ -296.42K
Tax Provision
---$ 0.00$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ -1.49M$ -2.46M$ -4.03M$ -2.48M$ -1.86M$ -296.42K
Basic EPS
$ -0.02$ -0.02$ -0.04$ -0.03$ -0.02$ >-0.01
Diluted EPS
$ -0.02$ -0.02$ -0.04$ -0.03$ -0.02$ >-0.01
Basic Average Shares
$ 483.83M$ 115.14M$ 106.25M$ 93.97M$ 85.60M$ 85.10M
Diluted Average Shares
$ 368.69M$ 115.14M$ 106.25M$ 93.97M$ 85.60M$ 85.10M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
$ -533.88K$ 2.13M$ 4.29M$ 1.27M$ 1.63M$ 215.11K
Net Income From Continuing And Discontinued Operation
$ -3.16M$ -2.66M$ -4.03M$ -2.48M$ -1.86M$ -296.42K
Normalized Income
$ -1.24M--$ -2.48M$ -1.86M$ -296.42K
Interest Expense
$ 216.46K--$ 1.27M$ 227.01K$ 81.31K
$ -3.37M$ -2.45M$ -6.31M$ -1.27M$ -1.63M$ -215.11K
$ -2.79M$ -2.13M$ -4.21M$ -1.27M$ -1.63M$ -215.11K
Currency in USD

Bioxytran Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis